NCT00344552 - Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

March 31, 2008

Study Completion Date

March 31, 2008

Conditions

Esophageal Cancer

Interventions

DRUG

Paclitaxel

Injection solution, IV, 100mg/sqm, once weekly, 7 weeks and over

Trial Locations (12)

Local Institution, Nagoya

Local Institution, Kashiwa-Shi

Local Institution, Sagamihara-Shi

Local Institution, Osaka

Local Institution, Suita-Shi

Local Institution, Saitama

Local Institution, Ōsaka-sayama

Local Institution, Takatsuki-Shi

Local Institution, Sunto-Gun

Local Institution, Utsunomiya

Local Institution, Chuo-Ku

Local Institution, Toshima-Ku